Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI

The hypothesis for ATTRACTIVE trial is that the intrathrombus thrombolysis with microcatheter or pierced balloon compared to manual aspiration thrombectomy will reduce the incidence of major adverse cardiovascular events(MACEs), including cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or heart failure rehospitalization, stent thrombosis and target-vessel revascularization at 1 year in STEMI patients with HTB undergoing PPCI.

Inclusion criteria

• Patients presenting with:

• Symptoms of myocardial ischemia lasting for ≥ 30 minutes AND
• Definite ECG changes indicating STEMI: ST elevation of greater than 0.1 mV in two contiguous limb leads or 0.2 mV in two contiguous precordial leads
• Referred for PPCI
• Within 12 hours of symptom onset, or 12-24 hours but still suffered from persistent symptom, hemodynamic instability or fatal arrhythmia
• High thrombus burden:

• TIMI thrombus grade 3 or 4 after emergency coronary angiography
• Or TIMI thrombus grade ≥3 after guidewire crossing or 1.5mm-diameter predilating the culprit lesion if emergency coronary angiography shows TIMI thrombus grade 5
• Informed consent

Exclusion criteria

• Rescue PCI after systemic thrombolysis
• Previous CABG history
• Life expectancy<1 year
• Active bleeding in past 6 months, hemorrhagic disorders and prone to bleeding
• Serious hepatic or kidney dysfunction
• Pregnancy and lactation
• Uncontrolled hypertension (>180/100mmHg)
• Previous hemorrhagic stroke or ischemic stroke in past 3 months
• Cardiogenic shock or cardio-pulmonary resuscitation
• Informed consent cannot be obtained or follow-up cannot be completed